Figures and tables index

From the following article

Protein carbamylation links inflammation, smoking, uremia and atherogenesis

Zeneng Wang, Stephen J Nicholls, E Rene Rodriguez, Outi Kummu, Sohvi Hörkkö, John Barnard, Wanda F Reynolds, Eric J Topol, Joseph A DiDonato & Stanley L Hazen

Nature Medicine 13, 1176 - 1184 (2007) Published online: 9 September 2007

doi:10.1038/nm1637

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Schematic illustration of pathways for promoting protein carbamylation and their link to atherosclerosis.

Full size figure and legend (39 KB)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Production of OCN- and homocitrulline (HCit) in the reaction of proteins with MPO/SCN-/H2O2.

Full size figure and legend (81 KB)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

MPO is a catalytic source for carbamylation at sites of inflammation and within human atherosclerotic plaque.

Full size figure and legend (95 KB)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

Potential pro-atherogenic effects of MPO-catalyzed protein carbamylation.

Full size figure and legend (96 KB)
Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 5

Case/control study examining the relationship between plasma concentrations of protein-bound HCit and the prevalence of atherosclerotic CVD.

Full size figure and legend (71 KB)
Figure 6 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 6

Case/control study examining the relationship between plasma abundance of protein-bound HCit and prospective risk for major adverse cardiac event (MACE; one or more of the following conditions: nonfatal MI, stroke, need for revascularization (Revasc.) or death).

Full size figure and legend (84 KB)
BACK TO ARTICLE